When your veterinarian suspects a genetic cause for your dog’s otherwise unexplainable symptoms, MoxxiTech is here to help.
RALLEE® Certified Canine Diagnostic Custom Panel includes all diseases tested in Panels 1-4, as well as custom and tailored analysis to discover de novo genetic mutations. This custom panel is designed for those veterinarians who suspect a genetic cause for their patient’s symptoms even though conventional genetic test results have provided negative or inconclusive results.
Learn more about genetic testing Order a Sample Collection Kit Veterinarians: Order NowFor symptoms involving: Drug Metabolism, Nervous System, Hearing, Vision
|
Number of Alleles Tested: 174 |
|
Condition |
Gene(s) |
|
AC-3933 Poor Metabolizer 1 |
CYP1A2 |
|
Achromatopsia 1-4 |
CNGA3, CNGB3 |
|
Acral Mutilation Syndrome |
GDNF |
|
Alexander Disease |
GFAP |
|
Beta Mannosidosis 1, 2 |
MANBA |
|
Bilateral Deafness and Vestibular Dysfunction |
MYO7A |
|
Cerebellar Ataxia 1,2 |
RAB24, KCNIP4 |
|
Cerebellar Cortical Degeneration |
SNX14 |
|
Cerebellar Hypoplasia |
VLDLR |
|
Collie Eye Anomaly |
NHEJ1 |
|
Cone Rod Dystrophy, Age of Onset Modifier |
MAP9 |
|
Cone-Rod Dystrophy 1-4 |
NPHP4, IQCB1, RPGRIP1 |
|
Congenital Eye Malformations |
SIX6 |
|
Congenital Myasthenic Syndrome 1-5 |
CHAT, CHRNE, COLQ |
|
Copper Toxicosis |
COMMD1 |
|
Deafness, Unilateral and Vestibular Dysfunction |
PTPRQ |
|
Degenerative Myelopathy |
SOD1 |
|
Demyelinating Peripheral Neuropathy |
SBF2 |
|
Dermoid Sinus |
FGF3 |
|
Early Onset Cataracts 1, 2 |
HSF4 |
|
Early Retinal Degeneration |
STK38L |
|
Epileptic Drug Resistance |
ABCB1 |
|
Episodic Falling Syndrome |
BCAN |
|
Fetal Onset Neuroaxonal Dystrophy |
MFN2 |
|
Fucosidosis Alpha |
FUCA1 |
|
Gangliosidosis 1-3 |
GLB1 |
|
Generalized Myoclonic Epilepsy |
DIRAS1 |
|
Generalized Progressive Retinal Atrophy 1, 2 |
ADAM9, CCDC66 |
|
Globoid Cell Leukodystrophy 1, 2 |
GALC |
|
GM2 Gangliosidosis Type I |
HEXA |
|
GM2 Gangliosidosis Type II 1, 2 |
HEXB |
|
Hepatic Copper Toxicosis |
ATP7B |
|
Hyperekplexia 1, 2 |
SLC6A5 |
|
Hypomyelination of Central Nervous System |
FNIP2 |
|
Hypophosphatasia |
ALPL |
|
Ivermectin Sensitivity 1, 2 |
ABCB1 |
|
L-2-Hydroxyglutaric Aciduria 1, 2 |
L2HGDH |
|
Lagotto Storage Disease |
ATG4D |
|
Laryngeal Paralysis Risk Factor |
RAPGEF6 |
|
Leber Congenital Amaurosis |
RPE65 |
|
Leukodystrophy 1, 2 |
CYTB, TSEN54 |
|
Leukoencephalopathy 1, 2 |
NAPEPLD |
|
Macular Corneal Dystrophy |
LOC489707 |
|
Merle/Cryptic Merle |
PMEL |
|
Micropthalmia |
RBP4 |
|
Mucopolysaccharidosis Type I |
IDUA |
|
Mucopolysaccharidosis Type IIIA 1, 2 |
SGSH |
|
Mucopolysaccharidosis Type IIIB 1, 2 |
NAGLU |
|
Multifocal Retinopathy I 1, 2 |
BEST1 |
|
Multifocal Retinopathy II |
BEST1 |
|
Multifocal Retinopathy III 1, 2 |
BEST1 |
|
Myoclonus Epilepsy of Lafora |
NHLRC1 |
|
Myotubular Myopathy 1, 2 |
MTM1 |
|
Narcolepsy 1-3 |
HCRTR2 |
|
Necrotising Encephalopathy |
SLC19A3 |
|
Neonatal Cerebellar Ataxia |
GRM1 |
|
Neonatal Encephalopathy With Seizures |
ATF2 |
|
Neuroaxonal Dystrophy 1-3 |
PLA2G6, TECPR2, VPS11 |
|
Neuronal Ceroid Lipofuscinosis 1 |
PPT1 |
|
Neuronal Ceroid Lipofuscinosis 2 |
TPP1 |
|
Neuronal Ceroid Lipofuscinosis 3 |
PPT1 |
|
Neuronal Ceroid Lipofuscinosis 4A 1 |
ARSG |
|
Neuronal Ceroid Lipofuscinosis 5 1, 2 |
CLN5 |
|
Neuronal Ceroid Lipofuscinosis 6 |
CLN6 |
|
Neuronal Ceroid Lipofuscinosis 7 |
MFSD8 |
|
Neuronal Ceroid Lipofuscinosis 8 1-4 |
CLN8 |
|
Neuronal Ceroid Lipofuscinosis 10 |
CTSD |
|
Neuronal Ceroid Lipofuscinosis 12 1, 2 |
ATP13A2 |
|
Oculocutaneous Albinism |
OCA2 |
|
Oculocutaneous Albinism Type IV 1-3 |
SLC45A2 |
|
Oculoskeletal Dysplasia I 1, 2 |
COL9A3 |
|
Oculoskeletal Dysplasia II |
COL9A2 |
|
Osteochondromatosis |
EXT2 |
|
Paroxysmal Dyskinesia |
PIGN |
|
Periodic Fever Syndrome |
MTBP |
|
Photoreceptor Dysplasia |
PPT1 |
|
Polyneuropathy 1-6 |
NDRG1, RAB3GAP1, ARHGEF10, GJA9 |
|
Pompe Disease |
GAA |
|
Primary Glaucoma 1, 2 |
ADAMTS10 |
|
Primary Lens Luxation |
ADAMTS17 |
|
Primary Open Angle Glaucoma 1-3 |
ADAMTS17 |
|
Primary Open Angle Glaucoma and/or Primary Lens Luxation |
ADAMTS17 |
|
Progressive Early Onset Cerebellar Ataxia |
SEL1L |
|
Progressive Retinal Atrophy 1-10 |
BBS4, HIVEP3, CNGA1, CNGB1, MERTK, NECAP1, SAG1, SLC4A3, TTC8, RHO |
|
Progressive Retinal Atrophy Type 2 |
C17H2orf71 |
|
Progressive Retinal Atrophy X-Linked Type 1, 1-3 |
RPGR |
|
Progressive Retinal Atrophy X-Linked Type 2 |
RPGR |
|
Progressive Rod-Cone Degeneration (PRCD-PRA) |
PRCD |
|
Protection Against Liver Copper Accumulation |
ATP7A |
|
Refractory Idiopathic Epilepsy |
ABCB1 |
|
Remitting Focal Epilepsy |
LGI2 |
|
Rod-Cone Dysplasia Type 1, 1-4 |
PDE6B |
|
Rod-Cone Dysplasia Type 3 |
PDE6A |
|
Selective Cobalamin Malabsorption 1-3 |
CUBN |
|
Sensory Ataxic Neuropathy |
tRNA-TYR |
|
Sensory Neuropathy |
FAM134B |
|
Spinal Dyraphism |
NKX2-8 |
|
Spinocerebellar Ataxia 1-7 |
SCN8A, KCNJ10, SPTBN2, CAPN1, ITPR1 |
|
Spongy Degeneration with Cerebellar Ataxia 1, 2 |
ATP1B2 |
|
Stargardt Disease |
ABCA4 |
|
Tremor |
PLP |
For symptoms involving: Development, Musculoskeletal System, Reproduction, Skin and Hair, Teeth and Oral Cavity
|
Number of Alleles Tested: 160 |
|
Condition |
Gene(s) |
|
Abortion |
BTBD17 |
|
Alexander Disease |
GFAP |
|
Amelogenesis Imperfecta 1-3 |
ACP4, ENAM |
|
Bernard-Soulier Syndrome Type C |
GP9 |
|
Beta Mannosidosis 1, 2 |
MANBA |
|
Centronuclear Myopathy 1, 2 |
BIN1, HACD1 |
|
CHILD-like Syndrome |
NSDHL |
|
Chondrodysplasia |
ITGA10 |
|
Chondrodystrophy (HT1) |
CFA 12 |
|
Ciliary Dyskinesia 1, 2 |
CCDC39, NME5 |
|
Cleft Lip and Palate |
ADAMTS20 |
|
Cleft Palate |
DLX6 |
|
Coat Color Dilution (d^1, d^2) |
MLPH |
|
Congenital Ichthyosis |
NIPAL4 |
|
Congenital Keratoconjunctivitis Sicca and Ichthyosiform Dermatosis |
FAM83H |
|
Congenital Myasthenic Syndrome 1-4 |
CHAT, CHRNE, COLQ |
|
Craniomandibular Osteopathy 1-4 |
SLC37A2, COL1A1, SLC35D1 |
|
Cushing’s Syndrome 1-6 |
GNAS |
|
Cyclic Neutropenia |
AP3B1 |
|
Decreased Fecundity |
GDF9 |
|
Dental Hypomineralization |
FAM20C |
|
Dermatosparaxis |
ADAMTS2 |
|
Dermoid Sinus |
FGF3 |
|
Disorder of Sexual Development |
HSD17B3 |
|
Disproportionate Dwarfism |
COL11A2 |
|
Dystrophic Epidermolysis Bullosa 1, 2 |
COL7A1 |
|
Ectodermal Dysplasia, 1-2 |
FOXI3, PKP1 |
|
Ehlers-Danlos Syndrome 1-4 |
COL5A1, TNXB |
|
Epidermolysis Bullosa |
PLEC |
|
Epidermolytic Hyperkeratosis |
KRT10 |
|
Episodic Falling Syndrome |
BCAN |
|
Exercise Induced Collapse |
DNM1 |
|
Exercise Induced Metabolic Myopathy |
ACADVL |
|
Exfoliative Cutaneous Lupus Erythematosus (ECLE) |
UNC93B1 |
|
Fanconi Syndrome |
FAN1 |
|
Fucosidosis Alpha |
FUCA1 |
|
Gangliosidosis 1-3 |
GLB1 |
|
Globoid Cell Leukodystrophy 1, 2 |
GALC |
|
Glycogen Storage Disease IIIa 1 |
AGL |
|
Glycogen Storage Disease VII 1, 2 |
PFKM |
|
Hereditary Methemoglobinemia 1, 2 |
CYB5R3 |
|
Hyperkeratosis |
FAM83G |
|
Hypomyelination of Central Nervous System |
FNIP2 |
|
Hypophosphatasia |
ALPL |
|
Hypothyroidism 1-4 |
TPO |
|
Hypotrichosis 1, 2 |
SGK3 |
|
Ichthyosis 1-4 |
ASPRV1, PNPLA1, SLC27A4, TGM1 |
|
Intestinal Cobalamin Malabsorption |
AMN |
|
Junctional Epidermolysis Bullosa |
LAMA3 |
|
Lethal Acrodermatitis |
MKLN1 |
|
Leukodystrophy |
CYTB |
|
Ligneous Membranitis |
PLG |
|
Limb Girdle Muscular Dystrophy Type 2F |
SGCD |
|
Malignant Hyperthermia |
RYR1 |
|
Merle (Mc, Mc+, Ma, Ma+, M, Mh) |
PMEL |
|
Mucopolysaccharidosis Type I 1 |
IDUA |
|
Mucopolysaccharidosis Type VI 1, 2 |
ARSB |
|
Mucopolysaccharidosis Type VII 1, 2 |
GUSB |
|
Muscular Dystrophy 1-8 |
COL6A1, DMD |
|
Muscular Hypertrophy |
MSTN |
|
Musladin Lueke Syndrome |
ADAMTSL2 |
|
Myotonia 1-3 |
CLCN1 |
|
Nasal Parakeratosis 1, 2 |
SUV39H2 |
|
Nemaline Myopathy |
NEB |
|
Oculocutaneous Albinism |
OCA2 |
|
Oculocutaneous Albinism Type IV 1-3 |
SLC45A2 |
|
Oculoskeletal Dysplasia 1, 2 |
COL9A2, COL9A3 |
|
Osteochondrodysplasia |
SLC13A1 |
|
Osteochondromatosis |
EXT2 |
|
Osteogenesis Imperfecta 1-5 |
COL1A1, COL1A2, SERPINH1 |
|
Palmoplantar Keratoderma |
KRT16 |
|
Paroxysmal Dyskinesia |
PIGN |
|
Periodic Fever Syndrome 1, 2 |
HAS2, MTBP |
|
Persistant Mullerian Duct Syndrome |
AMHR2 |
|
Pituitary Dwarfism |
LHX3 |
|
Polyneuropathy 1-6 |
NDRG1, RAB3GAP1, ARHGEF10, GJA9 |
|
Pompe Disease |
GAA |
|
Pyruvate Dehydrogenase Deficiency |
PDP1 |
|
Pyruvate Kinase Deficiency of Erythrocyte 1-6 |
PKLR |
|
Screw Tail |
DVL2 |
|
Selective Cobalamin Malabsorption 1-3 |
CUBN |
|
Spinal Dyraphism |
NKX2-8 |
|
Spinocerebellar Ataxia 6 |
CAPN1 |
|
Spondylocostal Dysostosis |
HES7 |
|
Tail Length (TBXT) |
T (TBXT) |
|
Van den Ende-Gupta Syndrome |
SCARF2 |
|
Vitamin D Deficiency Rickets Type II |
VDR |
|
X-linked Hypohidrotic Ectodermal Dysplasia 1, 2 |
EDA |
For symptoms involving: Blood, Cancer, Endocrine System, Gastrointestinal Tract, Heart, Immune System, Kidneys, Liver, Metabolism, Respiratory System
|
Number of Alleles Tested: 135 |
|
Condition |
Gene(s) |
|
Acute Respiratory Distress Syndrome |
ANLN |
|
Bernard-Soulier Syndrome Type C |
GP9 |
|
C3 Deficiency |
C3 |
|
Cardiomyopathy |
YARS2 |
|
Ciliary Dyskinesia 1, 2 |
CCDC39, NME5 |
|
Colorectal Hamartomatous Polyposis and Ganglioneuromatosis |
PTEN |
|
Congenital Dyshormonogenic Hypothyroidism |
SLC5A5 |
|
Copper Toxicosis |
COMMD1 |
|
Cushing’s Syndrome 1-6 |
GNAS |
|
Cyclic Neutropenia |
AP3B1 |
|
Cystinuria Type IA |
SLC3A1 |
|
Cystinuria Type IIA 1, 2 |
SLC3A1 |
|
Cystinuria Type IIB |
SLC7A9 |
|
Demyelinating Peripheral Neuropathy |
SBF2 |
|
Diffuse Cystic Renal Dysplasia and Hepatic Fibrosis |
INPP5E |
|
Dilated Cardiomyopathy |
PLN |
|
Elliptocytosis |
SPTB |
|
Exercise Induced Metabolic Myopathy |
ACADVL |
|
Factor VII Deficiency |
F7 |
|
Factor XI Deficiency |
F11 |
|
Fanconi Syndrome |
FAN1 |
|
Fatal Neonatal Interstitial Lung Disease |
LAMP3 |
|
Gallbladder Mucoceles |
ABCB4 |
|
Gastrointestinal Stromal Tumors 1-6 |
KIT |
|
Glycogen Storage Disease Ia |
G6PC |
|
Glycogen Storage Disease IIIa |
AGL |
|
Glycogen Storage Disease VII 1, 2 |
PFKM |
|
Hemophilia A 1-5 |
F8 |
|
Hemophilia B 1-7 |
F9 |
|
Hepatic Copper Toxicosis |
ATP7B |
|
Hereditary Nephritis |
COL4A5 |
|
Hereditary Methemoglobinemia 1, 2 |
CYB5R3 |
|
Hereditary Nephropathy 1-3 |
COL4A4, COL4A5 |
|
Hypocatalasia |
CAT |
|
Hypothyroidism 1-4 |
TPO |
|
Inflammatory Pulmonary Disease |
AKNA |
|
Intestinal Cobalamin Malabsorption |
AMN |
|
Invasive Transitional Cell Carcinoma |
BRAF |
|
Laryngeal Paralysis Risk Factor |
RAPGEF6 |
|
Lethal Acrodermatitis |
MKLN1 |
|
Leukocyte Adhesion Deficiency |
FERMT3 |
|
Leukocyte Adhesion Deficiency Type I |
ITGB2 |
|
Ligneous Membranitis |
PLG |
|
Lundehund Syndrome |
LEPREL1 |
|
Malignant Hyperthermia |
RYR1 |
|
May-Hegglin Anomaly |
MYH9 |
|
Mucopolysaccharidosis Type I |
IDUA |
|
Mucopolysaccharidosis Type VI 1, 2 |
ARSB |
|
Myeloperoxidase Deficiency |
MPO |
|
Myotubular Myopathy 1, 2 |
MTM1 |
|
Obesity and Food Motivation |
POMC |
|
Oculocutaneous Albinism Type IV 1-3 |
SLC45A2 |
|
Pancreatitis Variant 1-3 |
SPINK1 |
|
Periodic Fever Syndrome 1,2 |
HAS2, MTBP |
|
Pituitary Dwarfism |
LHX3 |
|
Polycystic Kidney Disease |
PKD1 |
|
Pompe Disease |
GAA |
|
Postoperative Hemorrhage |
P2RY12 |
|
Prekallikrein Deficiency |
KLKB1 |
|
Primary Hyperoxaluria |
AGXT |
|
Primary Polycythemia 1 |
JAK2 |
|
Protection Against Liver Copper Accumulation |
ATP7A |
|
Pyruvate Dehydrogenase Deficiency |
PDP1 |
|
Pyruvate Kinase Deficiency of Erythrocyte 1-6 |
PKLR |
|
Renal Cystadenocarcinoma |
FLCN |
|
Scott Syndrome |
ANO6 |
|
Selective Cobalamin Malabsorption 1-3 |
CUBN |
|
Severe Combined Immunodeficiency Disease 1,2 |
PRKDC, RAG1 |
|
Squamous Cell Carcinoma |
KITLG |
|
Thrombasthenia 1-3 |
ITGA2B |
|
Thrombocytopenia 1, 2 |
TUBB1 |
|
Thrombopathia 1-3 |
RASGRP1 |
|
Trapped Neutrophil Syndrome |
VPS13B |
|
Upper Airway Syndrome |
ADAMTS3 |
|
Urolithiasis |
SLC2A9 |
|
Vitamin D Deficiency Rickets Type II |
VDR |
|
Von Willebrand Disease Type I |
VWF |
|
Von Willebrand Disease Type II 1, 2 |
VWF |
|
Von Willebrand Disease Type III 1-3 |
VWF |
|
X-linked Severe Combined Immunodeficiency 1, 2 |
IL2RG |